Michael Santosuosso

3.0k total citations · 1 hit paper
22 papers, 2.5k citations indexed

About

Michael Santosuosso is a scholar working on Immunology, Infectious Diseases and Virology. According to data from OpenAlex, Michael Santosuosso has authored 22 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 11 papers in Infectious Diseases and 6 papers in Virology. Recurrent topics in Michael Santosuosso's work include Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (9 papers) and Tuberculosis Research and Epidemiology (7 papers). Michael Santosuosso is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (9 papers) and Tuberculosis Research and Epidemiology (7 papers). Michael Santosuosso collaborates with scholars based in Canada, United States and France. Michael Santosuosso's co-authors include Zhou Xing, Anna Zganiacz, Sarah McCormick, Mark C. Poznansky, Xizhong Zhang, Elda Righi, Pierre Leblanc, Mary Hitt, Fabrizio Vianello and Jian‐Ping Yuan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Michael Santosuosso

22 papers receiving 2.4k citations

Hit Papers

Vascular normalizing dose... 2012 2026 2016 2021 2012 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Santosuosso Canada 17 1.4k 792 706 578 501 22 2.5k
Chen Zhao China 23 1.2k 0.8× 420 0.5× 576 0.8× 1.2k 2.1× 534 1.1× 64 2.7k
Maria Tagliamonte Italy 27 972 0.7× 391 0.5× 599 0.8× 764 1.3× 320 0.6× 78 2.0k
Arjen Q. Bakker Netherlands 25 1.3k 0.9× 607 0.8× 531 0.8× 707 1.2× 367 0.7× 49 2.7k
Hironori Yoshiyama Japan 30 1.6k 1.2× 415 0.5× 1.7k 2.4× 1.1k 2.0× 465 0.9× 84 3.7k
Roger P.M. Sutmuller Netherlands 24 3.4k 2.4× 361 0.5× 1.5k 2.2× 773 1.3× 474 0.9× 30 4.5k
Alessandra Nardin United States 29 1.4k 1.0× 417 0.5× 1.1k 1.5× 519 0.9× 233 0.5× 46 2.8k
Rafael Cubas United States 24 2.4k 1.7× 349 0.4× 1.1k 1.6× 688 1.2× 382 0.8× 42 3.6k
Serena Meraviglia Italy 31 2.8k 2.0× 332 0.4× 1.6k 2.3× 658 1.1× 336 0.7× 86 3.9k
Anja K. Wege Germany 23 1.0k 0.7× 365 0.5× 540 0.8× 402 0.7× 309 0.6× 54 2.1k
Scott A. Hammond United States 34 2.1k 1.5× 230 0.3× 1.7k 2.3× 753 1.3× 465 0.9× 82 3.8k

Countries citing papers authored by Michael Santosuosso

Since Specialization
Citations

This map shows the geographic impact of Michael Santosuosso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Santosuosso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Santosuosso more than expected).

Fields of papers citing papers by Michael Santosuosso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Santosuosso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Santosuosso. The network helps show where Michael Santosuosso may publish in the future.

Co-authorship network of co-authors of Michael Santosuosso

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Santosuosso. A scholar is included among the top collaborators of Michael Santosuosso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Santosuosso. Michael Santosuosso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Yuhui, Jian‐Ping Yuan, Elda Righi, et al.. (2012). Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy. Proceedings of the National Academy of Sciences. 109(43). 17561–17566. 828 indexed citations breakdown →
2.
Righi, Elda, Satoshi Kashiwagi, J. P. Yuan, et al.. (2011). CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer. Cancer Research. 71(16). 5522–5534. 191 indexed citations
3.
Santosuosso, Michael, Elda Righi, Eric Hill, et al.. (2011). R5-SHIV Induces Multiple Defects in T Cell Function during Early Infection of Rhesus Macaques Including Accumulation of T Reg Cells in Lymph Nodes. PLoS ONE. 6(4). e18465–e18465. 10 indexed citations
4.
Chénine, Agnès L., Nagadenahalli B. Siddappa, Victor G. Kramer, et al.. (2010). Relative Transmissibility of an R5 Clade C Simian‐Human Immunodeficiency Virus Across Different Mucosae in Macaques Parallels the Relative Risks of Sexual HIV‐1 Transmission in Humans via Different Routes. The Journal of Infectious Diseases. 201(8). 1155–1163. 43 indexed citations
5.
Siddappa, Nagadenahalli B., Jennifer Watkins, Klemens J. Wassermann, et al.. (2010). R5 Clade C SHIV Strains with Tier 1 or 2 Neutralization Sensitivity: Tools to Dissect Env Evolution and to Develop AIDS Vaccines in Primate Models. PLoS ONE. 5(7). e11689–e11689. 35 indexed citations
6.
Santosuosso, Michael, et al.. (2009). HIV‐1 Envelope Protein gp120 Is Present at High Concentrations in Secondary Lymphoid Organs of Individuals with Chronic HIV‐1 Infection. The Journal of Infectious Diseases. 200(7). 1050–1053. 63 indexed citations
7.
Hovav, Avi‐Hai, Michael Santosuosso, Maytal Bivas‐Benita, et al.. (2009). X4 Human Immunodeficiency Virus Type 1 gp120 Down-Modulates Expression and Immunogenicity of Codelivered Antigens. Journal of Virology. 83(21). 10941–10950. 11 indexed citations
8.
McCormick, Sarah, Michael Santosuosso, Cherrie-Lee Small, et al.. (2008). Mucosally Delivered Dendritic Cells Activate T Cells Independently of IL-12 and Endogenous APCs. The Journal of Immunology. 181(4). 2356–2367. 13 indexed citations
9.
Small, Cherrie-Lee, Sarah McCormick, Navkiran Gill, et al.. (2008). NK Cells Play a Critical Protective Role in Host Defense against Acute Extracellular Staphylococcus aureus Bacterial Infection in the Lung. The Journal of Immunology. 180(8). 5558–5568. 100 indexed citations
10.
Stevceva, Liljana, Angela Carville, Beatriz Pacheco, et al.. (2008). The Efficacy of T Cell-Mediated Immune Responses Is Reduced by the Envelope Protein of the Chimeric HIV-1/SIV-KB9 Virus In Vivo. The Journal of Immunology. 181(8). 5510–5521. 12 indexed citations
11.
Santosuosso, Michael, Sarah McCormick, Xizhong Zhang, et al.. (2007). Mucosal Luminal Manipulation of T Cell Geography Switches on Protective Efficacy by Otherwise Ineffective Parenteral Genetic Immunization. The Journal of Immunology. 178(4). 2387–2395. 65 indexed citations
12.
Santosuosso, Michael, Sarah McCormick, Xizhong Zhang, Anna Zganiacz, & Zhou Xing. (2006). Intranasal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances Protection by Parenteral Mycobacterium bovis BCG Immunization against Pulmonary Tuberculosis. Infection and Immunity. 74(8). 4634–4643. 153 indexed citations
13.
Zhang, Xizhong, Maziar Divangahi, Patricia Ngai, et al.. (2006). Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene. Vaccine. 25(7). 1342–1352. 62 indexed citations
14.
Santosuosso, Michael, Sarah McCormick, & Zhou Xing. (2005). Adenoviral Vectors for Mucosal Vaccination Against Infectious Diseases. Viral Immunology. 18(2). 283–291. 60 indexed citations
15.
Santosuosso, Michael, Xizhong Zhang, Sarah McCormick, et al.. (2005). Mechanisms of Mucosal and Parenteral Tuberculosis Vaccinations: Adenoviral-Based Mucosal Immunization Preferentially Elicits Sustained Accumulation of Immune Protective CD4 and CD8 T Cells within the Airway Lumen. The Journal of Immunology. 174(12). 7986–7994. 141 indexed citations
16.
Malowany, Janet I., Sarah McCormick, Michael Santosuosso, et al.. (2005). Development of Cell-Based Tuberculosis Vaccines: Genetically Modified Dendritic Cell Vaccine Is a Much More Potent Activator of CD4 and CD8 T Cells Than Peptide- or Protein-Loaded Counterparts. Molecular Therapy. 13(4). 766–775. 25 indexed citations
17.
Xing, Zhou, Michael Santosuosso, Sarah McCormick, et al.. (2005). Recent Advances in the Development of Adenovirus- and Poxvirus- Vectored Tuberculosis Vaccines. Current Gene Therapy. 5(5). 485–492. 34 indexed citations
18.
Zganiacz, Anna, Michael Santosuosso, Jun Wang, et al.. (2004). TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. Journal of Clinical Investigation. 113(3). 401–413. 170 indexed citations
19.
Wang, Jun, Lisa Thorson, Richard W. Stokes, et al.. (2004). Single Mucosal, but Not Parenteral, Immunization with Recombinant Adenoviral-Based Vaccine Provides Potent Protection from Pulmonary Tuberculosis. The Journal of Immunology. 173(10). 6357–6365. 314 indexed citations
20.
Zganiacz, Anna, Michael Santosuosso, Jun Wang, et al.. (2004). TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. Journal of Clinical Investigation. 113(3). 401–413. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026